Advertisement
No access
Reports

Conservation of the Chk1 Checkpoint Pathway in Mammals: Linkage of DNA Damage to Cdk Regulation Through Cdc25

Science
5 Sep 1997
Vol 277, Issue 5331
pp. 1497-1501

Abstract

In response to DNA damage, mammalian cells prevent cell cycle progression through the control of critical cell cycle regulators. A human gene was identified that encodes the protein Chk1, a homolog of the Schizosaccharomyces pombe Chk1 protein kinase, which is required for the DNA damage checkpoint. Human Chk1 protein was modified in response to DNA damage. In vitro Chk1 bound to and phosphorylated the dual-specificity protein phosphatases Cdc25A, Cdc25B, and Cdc25C, which control cell cycle transitions by dephosphorylating cyclin-dependent kinases. Chk1 phosphorylates Cdc25C on serine-216. As shown in an accompanying paper by Peng et al. in this issue, serine-216 phosphorylation creates a binding site for 14-3-3 protein and inhibits function of the phosphatase. These results suggest a model whereby in response to DNA damage, Chk1 phosphorylates and inhibits Cdc25C, thus preventing activation of the Cdc2–cyclin B complex and mitotic entry.

Get full access to this article

View all available purchase options and get full access to this article.

REFERENCES AND NOTES

1
Elledge S. J., Science 274, 1664 (1996).
2
Deng C., et al., Cell 82, 67 (1995);
Brugarolas J., et al., Nature 377, 552 (1995);
Waldman T., et al., ibid. 381, 713 (1996).
3
Degenerate primers GGNGGNGAGT/CT/CTNATGGAT/CTT and TGGACAGGCCAAAGTC to conserved motifs in the kinase domains of spChk1 were used to screen a human B cell library by PCR. Four of 135 clones showed similarity to spChk1, and one was used to probe 2 × 105 plaques from a λACT human B cell cDNA library. We identified two CHK1 cDNAs.
4
Kozak M., Cell 44, 283 (1986).
5
Fogarty P., et al., Curr. Biol. 7, 418 (1997);
Sibon O. C. M., et al., Nature 388, 93 (1997).
6
K. Laake et al., Genes Chromosomes Cancer 18, 175 (1997);
Vorechovsky I., et al., Cancer Res. 56, 2726 (1996);
; H. Gabra et al., ibid., p. 950.
7
Y. Sanchez, C. Wong, S. J. Elledge, unpublished results.
8
Chen G., Lee E. Y. H. P., J. Biol. Chem. 271, 33693 (1996);
Lakin N. D., et al., Oncogene 13, 2707 (1996).
9
We made recombinant baculovirus encoding glutathione-S-transferase (GST) fusion proteins to hChk1 (GST-hChk1) or to a mutation of hChk1 in which Asp at position 130 was mutated to Ala [GST-hChk1(D130A)] (pYS71). These recombinants were made by introducing an Nde I site at the first ATG codon of the hChk1 open reading frame using PCR, and subcloning the hChk1 cDNA as an Nde I–Eco RI fragment into pGEX2Tcs, generating pYS45. The Xba I–Eco RI fragment from pYS45 containing GST-hChk1 was subcloned into PVL1393, which was cut with Xba I and Eco RI, generating pYS63. The GST-hChk1(D130A) mutant was generated by PCR, and the Xho I–Xmn I fragment containing the mutation was used to replace the wild-type fragment, generating pYS64. The GST-hChk1(D130A) fragment from pYS64 was sublconed into the baculovirus transfer vector by using the Univector plasmid fusion strategy (X. Liu and S. Elledge, unpublished results). Viruses were generated by standard methods (Baculogold, Pharmingen). Recombinant GST-hChk1 protein was isolated from infected Hi5 insect cells on glutathione (GSH) agarose. Cdc25C was cloned into pET15b (Novagen) and purified as outlined by the manufacturer.
10
Walworth N. C., Davey S., Beach D., Nature 363, 368 (1993);
al-Khodairy F., et al., Mol. Biol. Cell 5, 147 (1994);
Walworth N. C., Bernards R., Science 271, 353 (1996).
11
Enoch T., Nurse P., Cell 60, 665 (1990).
12
Rhind N., Furnari B., Russell P., Genes Dev. 11, 504 (1997).
13
Jin P., Gu Y., Morgan D., J. Cell Biol. 134, 963 (1996).
14
M. J. O′Connell,
Raleigh J. M., Verkade H. M., Nurse P., EMBO J. 16, 545 (1997).
15
Lew D. J., Kornbluth S., Curr. Opin. Cell Biol. 8, 795 (1996).
16
Terada Y., Tatsuka M., Jinno S., Okayama H., Nature 376, 358 (1995).
17
Kinase reactions contained GST-hChk1 bound to GSH agarose and either His6-hCdc25C GST-hCdc25A, GST-hCdc25B, GST-hCdc25C, or GST-hCdc25C- (200–256) (amino acids 200 to 256 of Cdc25). Kinase reactions contained 1 to 3 μg of GST-hChk1 or GST-hChk1(D130A) protein on beads and soluble substrate in 20 mM Hepes (pH 7.4), 10 mM MgCl2, 10 mM MnCl2, 2 μM adenosine triphosphate (ATP), and 15 μCi of [γ-32P]ATP for 30 min at 30°C. To determine the site on Cdc25C phosphorylated by hChk1, we carried out kinase reactions in a buffer consisting of 50 mM tris (pH 7.4), 10 mM MgCl2, 10 μM ATP, 1 mM dithiothreitol (DTT), and 10 μCi of [γ-32P]ATP. Proteins were separated by SDS-PAGE, transferred to nitrocellulose membranes, and visualized by autoradiography. The nitrocellulose membrane containing His6-Cdc25C was excised, blocked with 0.5% polyvinylpyrrolidone (PVP-40) in 100 mM acetic acid for 30 min at 37oC, washed six times with water, and digested with TPCK trypsin (Worthington) at a final concentration of 30 mg/ml in 0.1 M NH4CO3 (pH 8.0). Further digestion on selected high-pressure liquid chromatography (HPLC) fractions was performed with 2 units of proline-specific endopeptidase (ICN) in 0.1 M sodium phosphate, 5 mM EDTA (pH 7.4) at 37oC for 16 hours. Samples were acidified in 1% trifluoroacetic acid (TFA) and loaded onto a Vydac C18 column (25 cm by 0.46 cm inner diameter). Reverse-phase HPLC was performed at 37oC. Reactions were loaded in 0.1% TFA (buffer A) and eluted with a gradient from 0 to 60% buffer B (90% acetonitrile, 0.095% TFA). Fractions were collected at 0.5-min intervals up to 90 min and counted for radioactivity. Selected fractions were immobilized on Sequenlon-AA membrane discs (Millipore) for NH2-terminal sequencing. Manual Edman degradation was done as described (21) with a coupling and cleavage temperature of 55oC.
18
Y. Sanchez et al., data not shown.
19
Ogg S., Gabrielli B., Piwnica-Worms H., J. Biol. Chem. 269, 30461 (1994).
20
Peng C.-Y., et al., Science 277, 1501 (1997).
21
Bodwell J. E., et al., J. Biol. Chem. 266, 7549 (1991);
Sullivan S., Wong T. W., Anal. Biochem. 197, 65 (1991).
22
We thank A. Baldini for assistance with mapping; T. Carr for sharing unpublished information; P. Sen for making the S216A mutants of Cdc25C; N. Walworth, W. Harper, M. Huang, and J. Bachant for helpful comments; and D. Leibham and J. Thompson for technical assistance. Support was by a NIH postdoctoral fellowship GM17763 to Y.S. and a NIH grant GM44664 to S.J.E. H.P.-W. is an Associate Investigator of the Howard Hughes Medical Institute. S.J.E. is a Pew Scholar in the Biomedical Sciences and an Investigator of the Howard Hughes Medical Institute.

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 277 | Issue 5331
5 September 1997

Submission history

Received: 28 May 1997
Accepted: 4 August 1997
Published in print: 5 September 1997

Permissions

Request permissions for this article.

Authors

Affiliations

Helen Piwnica-Worms
Y. Sanchez, C. Wong, S. J. Elledge, Verna and Marrs McLean Department of Biochemistry, Department of Molecular and Human Genetics, Howard Hughes Medical Institute, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
R. S. Thoma, Z. Wu, H. Piwnica-Worms, Department of Cell Biology and Physiology, Howard Hughes Medical Institute, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
R. Richman, Department of Cell Biology, Howard Hughes Medical Institute, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

Notes

*
To whom correspondence should be addressed. E-mail: [email protected]

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. Inhibition of Chk2 promotes neuroprotection, axon regeneration, and functional recovery after CNS injury, Science Advances, 8, 37, (2022)./doi/10.1126/sciadv.abq2611
    Abstract
  2. DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2, Science, 287, 5459, (1824-1827), (2000)./doi/10.1126/science.287.5459.1824
    Abstract
  3. Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome, Science, 286, 5449, (2528-2531), (1999)./doi/10.1126/science.286.5449.2528
    Abstract
  4. Mitotic and G2 Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216, Science, 277, 5331, (1501-1505), (1997)./doi/10.1126/science.277.5331.1501
    Abstract
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Register for free to read this article

As a service to the community, this article is available for free. Login or register for free to read this article.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Full Text

FULL TEXT

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media